Find Oncologists

By Editorial Team
⚠ Medical Disclaimer: This directory is provided for informational purposes only and does not constitute medical advice. Off-label use of any medication, including ivermectin, mebendazole, and fenbendazole, should only be undertaken under the supervision of a licensed healthcare provider. Always consult your oncologist before adding any complementary therapy to your cancer treatment plan.

Information is one of the most powerful tools available when you or a loved one is facing a critical healthcare decision — especially when choosing a hospital or care team for cancer treatment. This choice can directly impact outcomes and quality of life, making careful evaluation essential.

Many cancer patients quickly discover that everyone around them has advice: drink this, take that supplement, see this therapist, stop eating certain foods, start eating others. While most suggestions come from a place of genuine care, the sheer volume of information can become overwhelming.

For patients, cancer is usually a new and unfamiliar experience. Few people have the medical knowledge or practical experience to evaluate the flood of recommendations that often follows a diagnosis. One of the biggest risks is trying to do too many things at once — mixing pieces from different sources without a coherent treatment strategy.

For these reasons, it is often best to seek care from a qualified medical team or specialized clinic that can provide a structured and personalized treatment plan. Working with experienced oncologists ensures that therapies — whether conventional, supportive, or integrative — are coordinated safely. Whenever possible, consult specialists with extensive experience treating your specific type of cancer, ideally within reputable centres or multidisciplinary programs.

Find Oncologists (Cancer Specialists) in the USA

The Find a Cancer Doctor database is made available by ASCO (American Society of Clinical Oncology) as an informational resource for patients and caregivers. The database includes names of physicians and health professionals from certain ASCO membership categories who have given their permission to be identified publicly.

→ Find a Cancer Doctor (ASCO / cancer.net)

World's Best Cancer Hospitals 2025–2026

Several independent organizations evaluate hospitals based on patient outcomes, clinical expertise, research output, and advanced treatment capabilities:

Ranking Body Resource How to Use
Newsweek / Statista World's Best Specialized Hospitals 2026 Select "Oncology" under the specialty filter
U.S. News & World Report Best Hospitals for Cancer 2025–26 Top 15 US hospitals for adult cancer care
U.S. News – Pediatric Best Children's Hospitals for Pediatric Cancer Top-ranked for childhood cancers
World's Best Cancer Hospitals Rankings

Find Integrative Oncologists in USA, Mexico, Europe & Asia

The following directories can help you locate practitioners who combine conventional oncology with evidence-informed complementary approaches:

Directory Coverage & Notes
National Directory of Integrative Oncology Providers USA-focused; curated list of integrative oncology centres
Integrative Oncology Providers (Glenn Sabin) USA; cancer wellness expert's personally vetted list
Heal Navigator USA, Mexico, Europe & Asia; searchable map of integrative providers
How to Starve Cancer (Jane McLelland) Global; doctors familiar with the McLelland off-label drug protocol
Nancy's List (Nancy Novack) Survivor-compiled directory of integrative practitioners and healing centres
OncANP: Find a Naturopathic Oncologist Use the "Display only FABNO" filter to find board-certified naturopathic oncologists
University of Arizona IM Graduates Search "Oncology" in the specialty filter among Andrew Weil Center IHeLp graduates
MCS Formulas: Hyperthermia & IV Clinics Map Global map of clinics offering hyperthermia and intravenous cancer treatments
Note on Terminology: While the term "alternative" might suggest opposition to conventional oncology, we prefer "complementary," "integrative," or "holistic." These terms better capture the role of these approaches as part of a personalized, value-added menu of strategies — not a replacement for conventional care, but a coordinated enhancement of it.

Clinics Prescribing Ivermectin, Mebendazole & Related Protocols

Prescribing ivermectin and mebendazole for cancer is off-label and typically occurs in integrative, functional, or metabolic medicine settings, often as adjuncts to standard care. These drugs are investigated based on preclinical evidence showing antiproliferative activity. Availability varies by country; in the US, compounding pharmacies may prepare customised doses. Always consult a licensed provider.

Care Oncology Clinic

Locations USA (virtual & select physical sites) & UK — 3705 Saunders Avenue, Richmond, VA 23227
Contact info@careoncology.com
Specialty Metabolic oncology; COC Protocol (mebendazole 100 mg/day + metformin + atorvastatin + doxycycline). May incorporate ivermectin in custom plans. Focused on adjunctive care across cancer types including glioma.
Website careoncology.com

Internal Healing & Wellness MD

Location 255 Ed English Dr, Suite A, Shenandoah, TX — Tel: (281) 651-2352
Specialty Functional medicine; prescribes ivermectin and fenbendazole (analogous to mebendazole) for cancer. Uses protocols incorporating ivermectin + fenbendazole + Vitamin E / curcumin / CBD for immune modulation.
Website internalhealingandwellnessmd.com

Riordan Clinic

Location Wichita, KS & Overland Park, KS, USA
Specialty Integrative oncology with high-dose IV Vitamin C (central in mitochondrial-targeting hybrid protocols). Associated with holistic/nutritional testing; open to repurposed drug discussion in personalised plans.
Website riordanclinic.org

Hope4Cancer Treatment Centers

Locations Playas de Tijuana & Cancún, Mexico
Specialty Alternative and integrative oncology using root-cause approaches. Incorporates ivermectin-based protocols combined with bio-immunotherapy, detox, and nutritional medicine. Programs typically 3 weeks; international patients welcome.
Website hope4cancer.com

Dr. William Makis (Virtual / Canada-based)

Location Virtual (Canada-based; serves global patients)
Specialty Oncology specialist offering ivermectin/fenbendazole/mebendazole protocols across various cancers. Reports world's largest ivermectin cancer clinic with documented tumour marker responses. Dosages are weight-based: ivermectin 0.5–2.5 mg/kg/day; fenbendazole 222–1,000 mg/day.
Contact makisw79@yahoo.com (only verified contact)
Substack makismd.substack.com
⚠ Scam Alert (Dr. Makis, Jan 2025): There are many scams using Dr. Makis's photos on Facebook, WhatsApp, and Telegram. He is NOT on any of these platforms and does not have a website. The only verified contact is makisw79@yahoo.com. Any other variation of this email is fraudulent.

Integrated Medical Alliance (IMA) Affiliated Providers

Coverage USA & Global
Details The IMA Cancer Care Guide (Dr. Paul Marik) includes ivermectin, mebendazole, and niclosamide as adjunctive anti-cancer agents. Affiliated providers prescribe these in coordinated plans. Formerly known as the FLCCC Alliance.
Directory imahealth.org/providers

City of Hope Cancer Center

Location Duarte, CA, USA (clinical trials)
Details Conducts clinical trials combining ivermectin with pembrolizumab for triple-negative breast cancer. Ivermectin use here is within trial settings, not routine off-label prescribing.
Website cityofhope.org

★ The Wellness Company — All 50 US States (Telemedicine)

Specialty Family Medicine, Functional Medicine. Telemedicine/online consultation serving all 50 US states.
Services Prescribes ivermectin and mebendazole via licensed providers. Products compounded and dispensed by a licensed US-based pharmacy. Researched and approved by Dr. Peter McCullough.
Website twc.health (use code ONEDAYMD)

Other References (Additional Providers)

  1. The Karlfeld Center, Idaho, USA — Joe Tippens interview with Dr. Karlfeldt
  2. AM Medical LLC — Integrative health clinic, Washington State
  3. Dr. LaValley MD Protocols — Consultant MD (TX & Nova Scotia); consults your treating physician
  4. Oasis of Hope, Mexico
  5. ChemoThermia Oncology Center, Turkey

Related: Best Alternative Cancer Treatment Centers in the United States

Integrated Medical Alliance (IMA) Observational Cancer Study: Participating Providers

The IMA (formerly FLCCC Alliance) has partnered with renowned breast cancer physician and researcher Kathleen Ruddy, MD, to conduct an observational study in collaboration with five US clinics tracking patient responses to various adjunct cancer therapies using repurposed drugs.

Lead Investigators: Dr. Kathleen Ruddy & Dr. Paul Marik | Contributing Author: Dr. Pierre Kory

1. Health and Healing — Kathleen T. Ruddy, MD

Retired cancer surgeon trained at Memorial Sloan-Kettering; 28 years' practice; 10,000+ patients; MSc International Healthcare Leadership (McGill). Author: The End of Breast Cancer: A Virus and the Hope for a Vaccine.
Format Telemedicine only
Address 46 Green Village Road, Madison, New Jersey 07940
Contact Kathleenmrca@aol.com  |  (201) 323-2288

2. Leading Edge Clinic — Pierre Kory, MD, MPA & Scott Marsland, FNP-C

Specialised evaluation and individualized treatment plans for COVID-19, Long COVID, COVID vaccine injury syndromes, and integrated conventional/complementary cancer treatment via telehealth.
Format Telemedicine only — all 50 states
Address 213 Tioga St, #6834, Ithaca, New York 14851-9997
Contact practicemanager@drpierrekory.com  |  (608) 400-0141
Website drpierrekory.com

3. The James Clinic — Mollie James, DO, MPH, FACOS FACS, IFMCP

Board-certified in general surgery and critical care medicine; functional medicine integration; launched to fulfil unmet patient needs with direct physician–patient care free of conflicts of interest.
Format In-person & Telemedicine
Address 934 North 7th Street, Chariton, Iowa 50049
States AR, IA, IL, KY, MI, MO, NC, OK
Contact hello@jamesclinic.com  |  (636) 751-9440
Website jamesclinic.com

4. Meakin Metabolic Care — Charles Meakin, MD

Metabolic-focused oncology care; one of the IMA observational study's participating clinics.
Study Info drpierrekory.com/cancer-care-study

Oncologists Familiar with Thomas Seyfried's Press-Pulse Protocol

Thomas Seyfried's Press-Pulse protocol is an emerging metabolic approach emphasising restriction of glucose and glutamine (the "press") combined with targeted interventions such as hyperbaric oxygen or specific drugs (the "pulse") to exploit cancer cells' metabolic vulnerabilities. While still primarily research-based, several US-based integrative oncologists incorporate similar ketogenic metabolic therapies inspired by Seyfried's framework. Traditional board-certified oncologists explicitly referencing the full Press-Pulse protocol are rare; the following demonstrate alignment through their use of ketogenic diets, glucose restriction, and metabolic targeting.

Practitioner / Clinic Location Seyfried/Metabolic Connection Contact
Dr. Dawn Lemanne, MD
Oregon Integrative Oncology		 Ashland, OR Board-certified oncologist (Stanford-trained); personalised ketogenic diets, glucose-ketone index (GKI) monitoring, fasting during radiation/chemo oregonio.com
(541) 488-6261
Root Causes MD
Drs. Nasha Winters, Paul Anderson, Neil McKinney		 Fort Myers, FL Explicitly references Seyfried's metabolic theory; Terrain 10 framework; ketogenic/low-carb to restrict glucose; hyperthermia and IV nutrients as pulsed interventions rtcausesmd.com
Dr. Ian D. Bier, ND, PhD, LAc, FABNO
Human Nature Natural Health		 Portsmouth, NH Ketogenic diet + hyperbaric oxygen (HBO) — a core "pulse" in Seyfried's protocol — for metastatic cancers; cites KD + HBO synergy studies humannaturenaturalhealth.com
(603) 610-7778
Dr. Mel Schottenstein, NMD
Mitogenesis		 Scottsdale, AZ Directly cites Seyfried's theory on cancer as metabolic disease; personalised low-carb / high-fat plans targeting mitochondrial dysfunction mitogenesis.health

Related: Cancer as a Metabolic & Immune Disease: Diet, Drugs, and Science Explained (2026)

How to Choose a Specialist: Key Questions to Ask

Treat every clinic and specialist as though you are interviewing them for the most important position you will ever fill — because that is exactly what you are doing. The following questions will help you assess fit, experience, and transparency:

  1. How many patients have been treated with your type of cancer at your specific stage?
  2. What have the results been? (Ask for specifics: how many patients are still monitored, over what timeframe, on which regimen?)
  3. When a programme hasn't worked, what were the contributing factors?
  4. How long will I need to follow this programme?
  5. How feasible is this to maintain at home?
  6. Will I need additional support — a carer, nurse, or coordinator — to implement this at home?
  7. What will it cost in total? (Include consultancy fees, travel, supplements, and ongoing treatments.)
  8. Do I feel confident in, and comfortable with, this practitioner? Trust and communication are clinically significant factors.
  9. Can they connect me with a previous patient who is willing to share their experience — especially important if travelling abroad for treatment?
Some patients find it helpful to have a trusted friend assist with initial screening, comparing information before making personal contact. A second or third opinion from a separate oncologist is also always worth pursuing for major treatment decisions.
Disclosure: Cancer Advisor participates in affiliate programmes including The Wellness Company (referral code: ONEDAYMD) and Amazon Associates. Affiliate links are marked accordingly. This does not influence our editorial content. Information presented is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Off-label drug use should always be discussed with a licensed oncologist or physician. Last reviewed: June 2026.

Comments

Post a Comment

Popular posts from this blog

Ivermectin for Cancer Treatment: Protocols and Evidence (2026 Update)

By Editorial Team
Image
Ivermectin is a drug primarily used to treat parasitic infections, and it has attracted research interest for its potential biological effects in cancer models, particularly within integrative and experimental treatment contexts. Supporters point to hundreds of preclinical studies and case reports showing anti-tumor activity across multiple cancer types.  However, current mainstream oncology guidelines do not support ivermectin as a standard or evidence-based treatment for cancer, especially as a substitute for established therapies such as immunotherapy, targeted therapy, chemotherapy, or radiotherapy. So where does the truth lie? The answer is more nuanced than either side often suggests. Access to modern cancer care remains uneven globally. Advanced diagnostic testing, molecular profiling, and novel therapies are often more accessible in high-income healthcare systems or through comprehensive insurance coverage. In contrast, patients in lower-resource or impoverished settings m...
Read more

Fenbendazole and the Joe Tippens Protocol: Evidence, Risks, and Current Perspective (2026 Update)

By Editorial Team
Image
Introduction The Joe Tippens Protocol revolves around the off-label use of fenbendazole (a veterinary dewormer commonly sold as Panacur C or Safe-Guard) combined with various supplements for cancer. The Protocol has been gaining rapid interest over the past years following some  fenbendazole advanced cancer success stories . Joe Tippens popularized this approach after claiming it contributed to his remission from metastatic small-cell lung cancer in 2017. As of 2026, Joe Tippens remains alive and reports being cancer-free for over 8 years, continuing a maintenance version of the protocol. Fenbendazole is marketed for animals (e.g., Panacur C, Safe-Guard ) and has no regulatory approval for human cancer treatment . Evidence for anticancer effects is primarily preclinical or anecdotal , and clinical trials in humans are lacking. Important Disclaimer: Fenbendazole is not approved by the FDA, EMA, or any regulatory body for human use or canc...
Read more

Fenbendazole and Ivermectin for Cancer: A Case Series of Over 700 Patients (2026)

By Editorial Team
Image
Medically Reviewed by: OneDayMD Editorial Team | Last Updated: May 2026 Anecdotal reports and preliminary studies suggest that ivermectin and fenbendazole, both antiparasitic drugs, may have potential anticancer effects when used alongside other treatments.  Many people immediately dismiss the potential of ivermectin and fenbendazole when they learn it is “horse or dog medicine”. That initial reaction is overcome when genuine human success stories are told including the lack of serious side effects. The testimonials you are about to read are from individuals who have bravely shared their experiences in the hope of inspiring and uplifting others. These are raw human accounts, unfiltered by gatekeepers—not peer-reviewed studies—but they offer insights that may be valuable to those searching for options. However, we acknowledge that robust clinical trials are needed to provide more conclusive scientific evidence. Table of Contents: Editor's Preface Introduction Fenbendazole and Iverme...
Read more

Top 10 Cancer Fighting Supplements: Evidence Based Literature Review (2026 Update)

By Editorial Team
Image
Are you overwhelmed by conflicting advice on cancer, diet, and supplements ? You’re not alone. With so many claims out there, it’s hard to separate fact from fiction . Can certain foods lower your cancer risk ? Are some foods increasing it without you realizing? What about vitamin and mineral supplements —do they help prevent cancer, or could they actually increase your risk ? The term " anti-cancer supplements " can be misleading. While some nutrients support the body in cancer prevention or treatment, others may interfere with therapies or even pose risks. There are presently over 1,500 herbs and food supplements in commerce, many of them with claims in use against cancer. This guide compiles over 500 scientific r...
Read more

Fact Check: Can Ivermectin and Fenbendazole Help Treat Cancer?

By Editorial Team
Image
Ivermectin and fenbendazole, originally developed as antiparasitic drugs, are sparking hope in the fight against cancer, fueled by inspiring stories like those shared by actor  Mel Gibson on The Joe Rogan Experience , where he celebrated friends’ remarkable recoveries. While these medications aren’t yet standard cancer treatments, early research is uncovering exciting potential. Scientists are encouraged by promising lab studies and are calling for more clinical trials to confirm their effectiveness and ensure safe use in humans, paving the way for innovative, accessible therapies that could transform lives. Introduction and Context According to a January 22, 2025 fact-check article by AFP: "The anti-parasitic drugs ivermectin and fenbendazole are not currently recommended for cancer, but posts spread across social media touting the medications after actor  Mel Gibson claimed on the Joe Rogan Experience  that they cured his friends' cases of the disease. Oncology ex...
Read more

Exploring Ivermectin, Mebendazole and Fenbendazole as Aggressive Cancer Treatments: Research, Protocols, and Controversies (2026)

By Editorial Team
Image
Fenbendazole and ivermectin, both antiparasitic drugs that have shown potential in cancer treatment through several mechanisms, such as slowing cancer cell growth and boosting the immune response. Fenbendazole is being studied for its ability to disrupt energy production in cancer cells, effectively hindering their growth. Ivermectin, on the other hand, has been explored in combination with checkpoint inhibitors to boost the immune system's response to tumors—especially in challenging cases like triple-negative breast cancer. Introduction Cancer remains a leading cause of morbidity and mortality worldwide, with an increasing incidence of aggressive and treatment-resistant tumors such as triple-negative breast cancer (TNBC), pancreatic adenocarcinoma, and glioblastoma. Despite significant advances in targeted therapies and immunotherapies, many patients continue to face limited effective options, highlighting an urgent need for novel, affordable, and accessible treatment strategies....
Read more

Fenbendazole and Cancer: What the Science Really Shows (Evidence, Risks & Open Questions)

By Editorial Team
Image
Abstract Background:  Fenbendazole (FBZ), a benzimidazole anthelmintic approved for veterinary use, has attracted attention for potential anticancer activity based on laboratory findings and widespread anecdotal reports.  Objective:  To critically appraise the current evidence on fenbendazole and cancer using a peer‑review style framework.  Methods:  Narrative review of preclinical studies, publicly reported human case narratives, and safety signals, with emphasis on evidence hierarchy and translational limitations.  Results:  Preclinical data demonstrate antiproliferative effects via microtubule disruption and metabolic stress in vitro and in animal models. Human evidence is limited to uncontrolled case reports; no Phase I–III clinical trials or regulatory approvals for oncology exist. Safety data in humans are sparse, with hepatotoxicity signals reported.  Conclusions:  Fenben...
Read more

Fenbendazole vs Ivermectin for Cancer: Differences and Which Is Better?

By Editorial Team
Image
Cancer patients are increasingly inquiring about the use of the anthelmintic drugs Fenbendazole (FenBen) and Ivermectin (IVM) as potential treatments for cancer. Notably, these patients typically fall into two distinct groups, neither of which represents the usual stage 1 or 2 cancer cases where conventional therapies often show promise. The first group consists of older men whose lung or prostate cancer has recurred. Having undergone conventional treatments previously without success, they express skepticism about its effectiveness this time around. The second, larger group comprises younger patients under 40 dealing with aggressive breast cancer, colorectal cancer, or lymphoma—forms of early-onset cancers that appear to lack the typical mutations observed in traditional cases. This article aims to delve into the differences between Fenbendazole and Ivermectin by examining their me...
Read more

Dr. William Makis's Recommended Ivermectin Dosages for Cancer (2026)

By Editorial Team
Image
Last revised: June 2026 Integrative Oncology · Protocol Review A comprehensive synthesis of Dr Makis's clinical dosing regimens, benzimidazole combination strategies, the 2026 Hulscher observational cohort, pharmacokinetic rationale, safety monitoring requirements, and anonymised patient outcome data — presented with evidence grading. OneDayMD Editorial Team  |  Medically reviewed and updated  |  About Us Ivermectin combined with benzimidazoles (fenbendazole, mebendazole) represents an emerging area of repurposed oncology pharmacology. All protocols require physician supervision. Abstract Background: Dr William Makis MD (McGill Medicine; 110+ peer-reviewed publications) has treated cancer patients using repurposed antiparasitic agents since 2023, publicly documenting protocols and outcomes via Substack and X (@MakisMD). His approach centres on high-dos...
Read more

Fenbendazole and Ivermectin for Stage 4 Pancreatic Cancer: A Compilation of Case Reports and Mechanistic Insights (2026)

By Editorial Team
Image
OneDayMD  |  Integrative Oncology Review ISSN (Online) pending  •  Volume 1, Issue 1  •  Published: 10 August 2025  •  Updated: 15 June 2026 Case Series & Mechanistic Review Compiled tumour marker responses, radiologic outcomes, and mechanisms of anti-cancer action across an international patient cohort Last updated: 15 June 2026 DOI: pending  •  Cite as: OneDayMD Editorial Team. Antiparasitic Drug Repurposing in Stage 4 PDAC: A Compiled Case Series of 28 Patients. OneDayMD Integr Oncol Rev. 2025;1(1). Updated June 2026. Evidence Classification All case reports in this series represent CEBM Level 4–5 evidence (case reports and expert opinion). This compilation is hypothesis-generating. No randomised controlled trials of ivermectin, fenbendazole, or mebendazole for pancreati...
Read more

Archive

Show more